Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry

التفاصيل البيبلوغرافية
العنوان: Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry
المؤلفون: Enrico Fabris, Giulia Barbati, Antonio Cannatà, Matteo Castrichini, Gianfranco Sinagra, Marco Merlo, Paolo Manca, Vincenzo Nuzzi, Aneta Aleksova, Massimo Zecchin, Giuseppe Boriani
المساهمون: Nuzzi, V., Cannata, A., Manca, P., Castrichini, M., Barbati, G., Aleksova, A., Fabris, E., Zecchin, M., Merlo, M., Boriani, G., Sinagra, G.
المصدر: Web of Science
سنة النشر: 2020
مصطلحات موضوعية: Adult, Cardiomyopathy, Dilated, Male, medicine.medical_specialty, Heart disease, medicine.medical_treatment, Dilated cardiomyopathy, 030204 cardiovascular system & hematology, Ventricular Function, Left, 03 medical and health sciences, 0302 clinical medicine, Interquartile range, Internal medicine, Atrial Fibrillation, Permanent atrial fibrillation, Medicine, Humans, Sinus rhythm, 030212 general & internal medicine, Registries, Heart transplantation, Ejection fraction, business.industry, Atrial fibrillation, Stroke Volume, Middle Aged, medicine.disease, Prognosis, Long-term outcome, Chronic heart failure, Treatment Outcome, Heart failure, Cardiology, Female, Cardiology and Cardiovascular Medicine, business
الوصف: Background: Little is known about the role of different types of atrial fibrillation (AF) in dilated cardiomyopathy (DCM). We investigated the epidemiological and prognostic impact of different types of AF in DCM during long-term follow-up. Method: We evaluated consecutive DCM patients enrolled in the Trieste Muscle Heart Disease Registry. Uni- and multivariable, extended Kaplan-Meier and propensity score-matching analyses were performed for a composite outcome including death/heart transplantation/ventricular-assist device implantation. Results: Out of 1181 DCM patients (71% males, age 49 ± 15 years, left ventricular ejection fraction 33 ± 11%), 46 (3.9%) had baseline permanent AF (permAF), while 66 (5.6%) had a history of paroxysmal/persistent AF. Compared with sinus rhythm (SR) patients, permAF patients were older (48 ± 15 vs. 61 ± 11 respectively, p = 0.001), were more frequently in NYHA class III-IV (18% vs. 30%, p = 0.002) and had larger left atrium diameter (40 ± 8 vs. 50 ± 10 mm, respectively). Paroxysmal/persistent AF patients had intermediate characteristics between permAF and SR. During a median follow-up of 135 (75–210) months, 63 patients developed permAF (0.45 new cases/100patients/year). At multivariable analysis, permAF as a time-dependent variable was an independent outcome predictor (HR 2.45; 95% C.I. 2.61–3.63, p < 0.001), together with creatinine, NYHA class, restrictive filling pattern and moderate-severe mitral regurgitation, while paroxysmal/persistent AF was neutral. Propensity score-matching analysis confirmed the higher rate of primary outcome events in patients with baseline or incident permAF versus patients without permAF during a very long-term follow-up (70% vs. 20%, p < 0.001). Conclusions: PermAF in a large DCM cohort had low prevalence and incidence but had a relevant. prognostic role on hard outcomes.
تدمد: 1874-1754
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bf8c5a07fbe80cb0468b275c2bda404Test
https://pubmed.ncbi.nlm.nih.gov/32853666Test
حقوق: OPEN
رقم الانضمام: edsair.doi.dedup.....1bf8c5a07fbe80cb0468b275c2bda404
قاعدة البيانات: OpenAIRE